Diabetes Discharge Transitional CGM Study (DDT-CGM)

A trial with no phase registered on ClinicalTrials.gov. The registry status is active, not recruiting. It plans to enroll 120 participants.

Also called NCT04729985

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; single masking; primary purpose prevention
Phase
Not applicable
Enrolled
  • 120 participants (planned count) (from the registry)
Sponsor
Registry
  • NCT NCT04729985
Started
(actual) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
United States (from the registry)
Registry status
  • Active, not recruiting (from the registry)

Technical summary

Registry record NCT04729985. Randomized; single masking; primary purpose prevention. Start 2021-06-01 (actual); primary completion 2024-07-01 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Diabetes Discharge Transitional CGM Study (DDT-CGM)
Acronym
DDT-CGM
Condition
Diabetes Mellitus, Type 2
Intervention (Device)
CGM device with diabetic education, CGM education and a follow up protocol.
Lead sponsor
Intermountain Health Care, Inc. (class: other)
Collaborator
Abbott (class: industry)

Record details

Record id
cardio:ct-nct04729985
Content hash
96094805ab5f0e26629b2f99779be53cf242f611699166d0fec0bc1f8456776e